Inventor profile of:

Annick Goergler

City:

Colmar

Country:

France

Published Applications:

30

Last publication date:

2026-02-12

Top Assignees for applications by Annick Goergler

The entities that hold a legal rights for patent applications filed by inventor Goergler Annick:

Recent patent applications by Goergler Annick

Annick Goergler from Colmar, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-12
US20260042782A1
Chemistry; metallurgy

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

#2 | 2025-09-18
US20250289824A1
Chemistry; metallurgy

EGFR INHIBITOR FOR THE TREATMENT OF CANCER

#3 | 2025-08-28
US20250270234A1
Chemistry; metallurgy

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

#4 | 2024-05-16
US20240158418A1
Chemistry; metallurgy

EGFR Degraders to Treat Cancer Metastasis to the Brain or CNS

#5 | 2024-03-07
US20240076300A1
Chemistry; metallurgy

ISOINDOLINONE AND INDAZOLE COMPOUNDS FOR THE DEGRADATION OF EGFR

#6 | 2024-02-22
US20240059692A1
Chemistry; metallurgy

NEW INDAZOLE DERIVATIVES

#7 | 2024-01-18
US20240018156A1
Chemistry; metallurgy

SPIROCYCLIC COMPOUNDS

#8 | 2024-01-18
US20240018154A1
Chemistry; metallurgy

NEW INDAZOLE DERIVATIVES

#9 | 2024-01-04
US20240002390A1
Chemistry; metallurgy

NEW INDAZOLE ACETYLENE DERIVATIVES

#10 | 2023-04-13
US20230110648A1
Chemistry; metallurgy

Isoindolinone and indazole compounds for the degradation of EGFR

#11 | 2023-02-23
US20230054473A1
Chemistry; metallurgy

EGFR INHIBITORS FOR THE TREATMENT OF CANCER

#12 | 2023-01-19
US20230019060A1
Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS FOR MEDICAL TREATMENT

#13 | 2022-10-06
US20220315593A1
Chemistry; metallurgy

EGFR INHIBITORS FOR THE TREATMENT OF CANCER

#14 | 2022-10-06
US20220315592A1
Chemistry; metallurgy

EGFR INHIBITOR FOR THE TREATMENT OF CANCER

#15 | 2022-10-06
US20220315591A1
Chemistry; metallurgy

NEW EGFR INHIBITORS

#16 | 2022-05-05
US20220135571A1
Chemistry; metallurgy

THERAPEUTIC EGFR INHIBITORS

#17 | 2022-04-14
US20220112199A1
Chemistry; metallurgy

EGFR INHIBITOR FOR MEDICAL USE

#18 | 2021-03-18
US20210079005A1
Chemistry; metallurgy

Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers

#19 | 2021-03-11
US20210070763A1
Chemistry; metallurgy

Spirocyclic compounds

#20 | 2017-05-18
US20170137416A1
Chemistry; metallurgy

6-amino-5,6,7,8-tetrahydronaphthalen-2-yl or 3-aminochroman-7-yl derivatives

#21 | 2015-02-12
US20150045359A1
Chemistry; metallurgy

Morpholine compounds and uses thereof

#22 | 2013-01-03
US20130005988A1
Chemistry; metallurgy

2-AZETIDINEMETHANEAMINES AND 2-PYRROLIDINEMETHANEAMINES AS TAAR-LIGANDS

#23 | 2012-06-28
US20120165294A1
Chemistry; metallurgy

4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES

#24 | 2011-06-16
US20110144333A1
Human necessities

4,5-dihydro-oxazol-2yl derivatives

#25 | 2010-02-18
US20100041686A1
Chemistry; metallurgy

4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES

#26 | 2010-02-04
US20100029589A1
Human necessities

4,5-dihydro-oxazol-2YL derivatives

#27 | 2009-01-29
US20090029962A1
Chemistry; metallurgy

2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands

#28 | 2008-05-22
US20080119535A1
Chemistry; metallurgy

Aminomethyl-4-imidazoles

#29 | 2008-05-20
US10767784
-

Malonamide derivatives

#30 | 2008-04-24
US20080096906A1
Chemistry; metallurgy

AMINOMETHYL-2-IMIDAZOLES

InventorID:

14788 ⎘